Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-04-30

FDA Approved: NAFTIN — Supplemental Application (Legacy Pharma USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for NAFTIN (naftifine hydrochloride) submitted by Legacy Pharma USA Inc. The action approves an update to the product's …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NAFTIN (NAFTIFINE HYDROCHLORIDE)

Snippet

SUPPL AP for NAFTIN (NAFTIFINE HYDROCHLORIDE)